• Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Average Rating of "Buy" from Analysts

    Source: Buzz FX / 21 Dec 2024 02:07:12   America/Chicago


    Janux Therapeutics, Inc. (NASDAQ:JANX) Receives Average Rating of "Buy" from Analysts Written by MarketBeat December 21, 2024 Share Link copied to clipboard. Shares of Janux Therapeutics, Inc. ( NASDAQ:JANX - Get Free Report ) have earned a
    Read more...
Share on,